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The emergence of novel H1N1 has posed a situation that warrants urgent global attention. Though antiviral drugs are available in
mainstream medicine for treating symptoms of swine ﬂu, currently there is no preventive medicine available. Even when available,
they would be in short supply and ineﬀective in a pandemic situation, for treating the masses worldwide. Besides the development
of drug resistance, emergence of mutant strains of the virus, emergence of a more virulent strain, prohibitive costs of available
drugs, time lag between vaccine developments, and mass casualties would pose diﬃcult problems. In view of this, complementary
and alternative medicine (CAM) oﬀers a plethora of interesting preventive possibilities in patients. Herbs exhibit a diverse array
of biological activities and can be eﬀectively harnessed for managing pandemic ﬂu. Potentially active herbs can serve as eﬀective
anti inﬂuenza agents. The role of CAM for managing novel H1N1 ﬂu and the mode of action of these botanicals is presented here
in an evidence-based approach that can be followed to establish their potential use in the management of inﬂuenza pandemics.
The complementary and alternative medicine approach deliberated in the paper should also be useful in treating the patients with
serious inﬂuenza in non pandemic situations.
1.Introduction
Viruses are a serious threat to the health of people in
all parts of the world. For most bacterial diseases, several
eﬀective drugs are available, however, viral diseases are often
diﬃcult to treat primarily because viruses spread and mutate
very rapidly. The control and treatment of a viral infection
depends mainly on the availability of antiviral drugs, which
are few and usually are not virucidal but simply prevent
replication in the host. It has become imperative to develop
eﬀective medical strategies for the management of common
viral diseases like inﬂuenza, which can assume pandemic
proportions and become a major threat to humanity.
Complementary and alternative medicines have been used
eﬀectively by humans over several centuries for treating
various diseases and can be eﬀectively employed to target
the host response during inﬂuenza outbreaks [1] and are the
focus of the present paper.
2. Inﬂuenza Reassorted Virus:
Is aGlobalDisasterinthe Making?
2.1. Swine Flu: The Current Pandemic. The etymology of the
word Pandemic can be traced to a Greek word pandemos
“pertaining to all people” and has been derived from pan
–“ all” + demos – “people”. Pandemic is referred to as a
pervasive epidemic of contagious disease aﬀecting through-
out the whole of a country or one or more continents at
the same time. It relates basically to the virus’s geographical
spread rather than its severity. There have been three ﬂu2 Evidence-Based Complementary and Alternative Medicine
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Figure 1: The H1N1 Virus.
pandemics in the 20th century and these occurred in 1918,
1957, and 1968. Inﬂuenza A viruses are single-stranded RNA
viruses with an eight segmented genome and belong to the
family Orthomyxoviridae. The viral haemagglutinin (HA)
and neuraminidase (NA) proteins envelope glycoproteins
(Figure 1) and are the key antigens against which humoral
immune responses are directed.
2.2. Novel H1N1 Flu. Swine ﬂu is a highly contagious
respiratory disease of pigs with low mortality (1%–4%),
is species-speciﬁc in nature, and outbreak usually occurs
once in a year with an upsurge in Autumn and Winter in
temperate zones. One such virus, namely, Inﬂuenza A H1N1
virushasevolvedthecapacitytocrossspeciesbarrier(i.e.,pig
tohumans)andhasspreadwidelyamongsthumans.Thisled
to a pandemic situation covering nearly the entire globe with
asigniﬁcantpaceintermsofspread.Morethan213countries
and overseas territories or communities have reported labo-
ratory conﬁrmed cases of pandemic inﬂuenza H1N1, includ-
ing at least 16226 deaths. Novel H1N1 ﬂu is characterised
with the onset of sudden fever (>38◦C/100.4◦F), cough,
tiredness, headache, chills, loss of appetite aching muscles,
paining joints, runny nose, sneezing, and sore throat. In
case of acute respiratory infections, shortness of breath is
one of the additional symptoms. In addition to these mild
complications, diarrhoea, and vomiting are also observed in
nearly one out of four patients (Figure 2).
2.3. Novel H1N1 Flu: Impact Assessment, Mitigation, and
Control Measures. There is a signiﬁcant variation in number
of cases among diﬀerent regions identiﬁed by World Health
Organisation (WHO). The number of cases as of now
followed the trend American region > European > Western
Paciﬁc > South East Asian Region. The followup of H1N1
outbreak in April 2009, reaching Phase V and then VI has
exhibited a systematic spread from a single source to global
arena. By May 2009, it was established and anticipated that
the disease will attain pandemic proportions (Figure 3). The
entrance of H1N1 virus into the South Asian region with
maximal proportion of global population led to a signiﬁcant
increase in number of conﬁrmed cases, with a signiﬁcant
number of global deaths. Till 10 Feb 2010, the number of
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Figure 2: Symptoms of Swine ﬂu due to novel H1N1 viral attack.
conﬁrmed human cases of H1N1 in India were 29187 and
among these cases, the number of deaths had reached 1278
(Figure 4). The total number of cases has been reported from
more than 10 states of the country. A rise in number of cases
ofH1N1inthecomingmonthscanbeexpectedduetowinter
approaching.TheWHO,howevercontendsthatclimatedoes
not have any eﬀect.
A report published in May, 2009 revealed that maximal
number of conﬁrmed cases was reported in the age group
either <15 years or 15–29 years, though, more number of
deaths occurred in older people [2]. Immunocompromised
patients or old people with ageing or preexisting disorders
are more vulnerable, and therefore complementary and
alternative medicine can be used to boost the natural
immune system in a holistic manner. In addition, proper
preinfection and postinfection planning can also help in
controlling the mortality rate due to Swine ﬂu [3, 4].
3. Modern Therapeutic Interventions:
How Safe Are We?
Modern system of medicine is based on a medical model
that basically oﬀers symptomatic treatment and focuses
more on therapy. It emphasizes on the use of drugs,
mechanical testing, invasive treatments like surgery, and a
passive approach towards the patient. In modern medicine,
two classes of antiviral medication are currently available for
the treatment of seasonal human inﬂuenza. Neuraminidase
inhibitors like oseltamivir (Tamiﬂu), zanamivir (Relenza),
and adamantanes (rimantadine and amantadine). Interest-
ingly, the starting material for the synthesis of Tamiﬂu
is also a herb (Illicium verum). Genetic and phenotypicEvidence-Based Complementary and Alternative Medicine 3
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Figure 3: Conﬁrmed cases of H1N1 at global level & number of
deaths (April-Sep 2009).
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Figure 4: Conﬁrmed cases of H1N1 in India & number of deaths
(April-Sep 2009).
analyses indicate that H1N1 is susceptible to oseltamivir and
zanamivir, but resistant to the adamantanes. These drugs
mainly target three inﬂuenza envelope proteins: hemagglu-
tinin, neuraminidase, and the matrix 2 ion channel protein.
A recent study emphasized the urgent need for augmen-
tation of oseltamivir (Tamiﬂu) stockpiles with additional
antiviral drugs, including Zanamivir (Relenza), based on
an evaluation of the performance of these drugs in the
scenario that the 2009 H1N1 “Swine Flu” neuraminidase
(NA) were to acquire the Tamiﬂu-resistance (His274Tyr)
mutation, which is currently wide-spread in seasonal H1N1
strains [5]. Treatment with amantadines may lead to the
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Figure 5: Need for an alternative therapy to manage novel H1N1
viral infection.
rapid production of resistant viruses, and over-use of these
drugs has probably contributed to the recent spread of
resistance [6]. Laboratory studies have also shown that it
is possible that even the use of suboptimal doses of these
drugs as a prophylactic measure might contribute to the
development of drug resistance [7].
4.WhyAlternativesAreNeeded?
The need for alternatives arises because of some of the
following reasons (Figure 5).
5.Solutions fromNature
5.1. Learning from Traditional Wisdom. Complementary and
alternative medicine has been utilized for several years in
various parts of the world to alleviate human disease. The
preventive role of complementary and alternative medicine,
in particular, cannot be overemphasized. “Complementary”
implies that it joins conventional medicine as an equal
counterpart to make the healing process complete. Alter-
native medicine substitutes for conventional medicine. It
neither works with nor enhances conventional medicine,
but rather acts as its replacement. Complementary and
alternative medicine has been used for the well-being of the
general population, especially when conventional modern
medicine has failed to deliver and has also been used at
times in conjunction with conventional medicine to obtain
synergistic eﬀects.
The traditional Indian System of Medicine, namely,
Ayurveda [8], Traditional Chinese medicine (TCM) [8, 9],4 Evidence-Based Complementary and Alternative Medicine
Japanese traditional medicine (Kampo) [10], Unani [11],
Siddha, and so forth, belong to the category of comple-
mentary and alternative medicines. For some or the other
reason the alternative herbal treatment systems have so far
been unable to enter mainstream medicine [12], though
serious eﬀorts are being made, in view of their eﬀective-
ness, to develop a strong evidence-based standardization
of Ayurveda, Siddha, Unani, Traditional Chinese Medical
Therapy [13], and other CAM so that they can aptly ﬁt into
the modern medicinal framework.
Ayurveda, the traditional Indian system of medicine, has
been widely used since centuries and a number of plants
of the Indian subcontinent have been utilized for tackling
almost every human ailment. Ayurveda’s focus is more on
creating an energetic balance at the higher energetic or inner
level. It sees all life and nature as constantly evolving towards
a higher level of consciousness [14]. Ayurvedic formulations
have an impact at this higher level of consciousness, as
well as the more gross body level. Ayurveda seeks to
connect us with this intelligence inherent in nature. These
profound concepts, based upon an astute understanding of
theuniversallawsand practicalobservations abouttheworld
around, give us the indication about the holistic approach of
Ayurveda and its potential in alleviating many health-related
problems aﬄicting the whole of humanity. Several antiviral
agents have been isolated from plants as a result of chemical
and pharmacological studies in the recent years, and many
have been derived from leads based on Ayurvedic and
other traditional medicine principles. These agents include
a variety of polyphenols, ﬂavonoids, saponins, glucosides,
and alkaloids [15]. Here, we discuss various potential herbs
that have been evaluated for their eﬃcacy against ﬂu viruses
and hence can prove to be useful to combat the novel H1N1
pandemic.
5.1.1. Glycyrrhiza glabra. Also known as Yashtimadhu (San-
skrit), Mulathee (Hindi), and Licorice (English), Gly-
cyrrhiza glabra (Papilionaceae) derives its ﬂavour principally
from a sweet-tasting compound called anethole (“trans”-1-
methoxy-4-(prop-1-enyl)benzene). Additional sweetness in
licoricecomesfromglycyrrhizic acid, an antiviralcompound
signiﬁcantly sweeter than sugar [16]. Powdered licorice
root is an eﬀective expectorant, and has been used for
this purpose since ancient times, especially in Ayurvedic
medicine. The roots of the plant have been used for
throat and upper respiratory tract-related infections and
contain many phenolic compounds such as ﬂavonoids and
their glycosides, coumarin, and cinnamic acid derivatives.
Particularly from the Indian species, Glucosides, Liquiritin,
and Isoliquiritin have also been isolated. The active com-
poundsTriterpine,Saponins,particularlyGlycyrrhizinicacid
have shown antiviral activity [17]. Polysaccharide fractions
obtained from Glycyrrhiza glabra stimulate macrophages
[18] and hence elevate and assist immune stimulation
[19]. Also animal studies have revealed its eﬃcacy against
the inﬂuenza a virus that is mediated by stopping the
virus replication [20]. Glycyrrhizic acid present in the
plant inhibits virus growth and inactivates virus particles
[21].
5.1.2. Ocimum sanctum. O. sanctum, also known as Tulsi
(Hindi) and Holy Basil (English), is an aromatic plant of the
familyLamiaceae.Theplant,asawhole,isatreasurehouseof
potent compounds with its leaves, seeds, and roots, as well as
ﬂower being medicinally important and is considered divine
by the Hindus. O. sanctum is considered to be an adaptogen
par excellence [22, 23]. It harmonizes diﬀerent processes
in the body and is helpful in acclimatizing to stress. The
main chemical constituents of O. sanctum are oleanolic acid,
ursolic acid, rosmarinic acid, eugenol, carvacrol, linalool,
and β-caryophyllene [23]. The antiviral activity of eugenol
has been reported. Ocimum extracts are used in ayurvedic
remedies for common colds, headaches, stomach disorders,
inﬂammation,heartdisease,variousformsofpoisoning,and
malaria. Traditionally, O. sanctum is taken in many forms
as herbal tea, dried powder, fresh leaf, or mixed with ghee.
Essential oil extracted from Karpoora O. sanctum is mostly
used for medicinal purposes and in herbal cosmetics, and
is widely used in skin preparations due to its antimicrobial
activity [24]. Recent studies suggest that O. sanctum may
be a COX-2 inhibitor, like many modern painkillers, due to
its high concentration of eugenol (1-hydroxy-2-methoxy-4-
allylbenzene) [25]. O. sanctum is reported to be an eﬀective
treatment for diabetes and high cholesterol [26]. O. sanctum
also shows promise for protection against radiation damage
[27, 28]. O. sanctum leaves contain highest percentage of
essential oils, infusion of which is given in malaria. Juice
of the leaves is taken internally and is very eﬀective in skin
diseasessuchasitchesfungalinfections.Freshleavesalsocure
chronic fever and when mixed with honey and ginger juice,
it is useful in cough and bronchitis [29]. During the past
decade the plant has been extensively investigated and has
been shown to possess a range of biological activities such
as antibacterial activity [30], antifungal activity [31], and
antiviral activity [32]. Nitric oxide production was induced
by O. tenuiﬂorum extracts in stimulated peripheral blood
mononuclear cells in vitro and the active component(s)
responsible for immunomodulatory action were identiﬁed
[33]. The extract was also used to stimulate the cells
individually and in combination with mitogens as well [34].
TheantimicrobialpropertiesofO. sanctum makeitusefulfor
the management of novel H1N1 ﬂu.
5.1.3. Alium sativum. Alium sativum, also known as Lahsan
(Hindi) and Garlic (English), belongs to family Alliaceae. A.
sativum has been used throughout recorded chronicles for
both culinary and medicinal purposes. It has a characteristic
pungent, spicy ﬂavor. A. sativum has been used for hundreds
of years to treat fungal, parasitic, and viral infections, and
has anti-inﬂammatory properties that show promise for
prevention of cardiovascular disease. It is known to kill
inﬂuenza virus in vitro [35]. Researchers are focusing on an
extract of A. sativum called ajoene, which appears to protect
CD+ cells from attack by HIV early in the viral life cycle. At
low concentrations, the drug appears to have little toxicity,
and its anti-HIV activity is 45 times more powerful than
the drug dextran sulfate. Ajoene is found only in fresh A.
sativum and is not readily procurable. Recent investigations
reveal that A. sativum impairs the activity of the liverEvidence-Based Complementary and Alternative Medicine 5
enzymes that process protease inhibitors and raises the
protease inhibitor levels. The in vitro antiviral activity of A.
sativum extract (GE) on human cytomegalovirus (HCMV)
was also evaluated in tissue cultures, plaque reduction, and
early antigen assay. A dose-dependent inhibitory eﬀect of
GE was evident when GE was applied simultaneously with
HCMV [36]. The in vitro antiviral eﬀe c to fg a r l i ca g a i n s t
parainﬂuenza virus type 3 and human Rhinovirus type 2 has
also been evaluated [37].
5.1.4. Cocos nucifera. The coconut (Cocos nucifera)b e l o n g s
to the Family Arecaceae (palm family). The most common
form of its usage is the coconut oil, which is extracted
from the kernel of matured coconut (Cocos nucifera).
Throughout the tropical regions, it has been the primary
source of fat in the diets of millions of people since aeons.
Cocos nucifera oil has a long history of use, both as food
and as medicine, throughout the world. It holds a high
place of respect in Ayurvedic medicine in India. In folk
remedies around the world, coconut is used to treat a
wide assortment of ailments including abscesses, alope-
cia, amenorrhea, asthma, blenorrhagia, bronchitis, bruises,
burns, cachexia, calculus, colds, constipation, cough, debil-
ity, dropsy, dysentery, dysmenorrhea, earache, erysipelas,
fever, ﬂu, gingivitis, gonorrhea, hematemesis, hemoptysis,
jaundice, menorrhagia, nausea, phthisis, pregnancy, rash,
scabies, scurvy, sore throat, stomachache, swelling, syphilis,
toothache, tuberculosis, tumors, typhoid, venereal diseases,
and wounds [20]. It has been reported that certain fatty
acids,primarilymedium-chainfattyacids(MCFA),andtheir
derivatives(e.g.,monoglycerides)havepotentantiviralprop-
erties [59]. When C. nucifera o i li sc o n s u m e d ,t h em e d i u m -
chain triglycerides (MCTs) are broken down into individual
medium chain fatty acids and monoglycerides, which can
killorinactivatepathogenicmicroorganismsinsidethebody.
The antiviral action, attributed to monolaurin (the mono-
glyceride of lauric acid), is that of solubilizing the lipids and
phospholipids in the envelope of the pathogenic organisms
causing the disintegration of their outer membrane. There is
also evidence that MCFA interfere with the organism’s signal
transduction [60] and the antimicrobial eﬀect in viruses is
due to interference with virus assembly and viral maturation
[61].
5.1.5. Zingiber oﬃcinale. Zingiber oﬃcinale (Ginger) is a
plant which belongs to the family Zingiberaceae. The
characteristic odor and ﬂavor of ginger root is caused by
a mixture of zingerone, shogaols, and gingerols, volatile
oils that comprise of about one to three percent of the
weight of fresh ginger. In laboratory animals, the gingerols
increase the motility of the gastrointestinal tract and have
analgesic, sedative, antipyretic, and antibacterial properties
[62]. Ginger contains gingerol, a pungent ingredient of gin-
ger volatile oil with sulphur-containing compounds (allicin,
alliin, and ajoene), and enzymes (allinase, peroxidase, and
myrosinase). The antibiotic properties of allicin are well
known. The allicins have ﬁbrinolytic activity, which reduces
platelet aggregation by inhibiting prostaglandin E2. Com-
pounds in ginger also increase levels of antioxidant enzymes,
including superoxide dismutase and glutathione peroxidase,
which may be beneﬁcial in inﬂammatory reactions triggered
by viral infections [63]. Anti-inﬂuenza agents have been
isolated from Z. oﬃcinale.T N F - α, reported as anti-inﬂuenza
cytokine, has been reported to be present in ginger [64].
5.1.6. Phyllanthus emblica. The Indian gooseberry (Phyllan-
thus emblica,s y n .Emblica oﬃcinalis) is a deciduous tree
of the Euphorbiaceae family. It is also known as Amlaka
(sanskrit) and Amla (Hindi). In traditional Indian medicine,
dried and fresh fruits of the plant are used. All parts of the
plant, including the fruit, seed, leaves, root, bark, and ﬂow-
ers, are used in various Ayurvedic/Unani Medicine herbal
preparations. According to Ayurveda, Emblica oﬃcinalisfruit
issourandastringentintaste,withsweet,bitter,andpungent
secondary tastes.
Methanol extract of the fruit of Emblica oﬃcinalis has
potent inhibitory action against human immunodeﬁciency
virus-1 reverse transcriptase. Emblica oﬃcinalis aqueous
extracts are used in Cuban traditional medicine for their
antiviral activity against Hepatitis B virus and A and B
inﬂuenza virus. The cytotoxicity of the extract was tested
by means of colony-forming ability and growth-inhibition
assays, as well as by measuring the mitotic index. Apop-
tosis induction and cell-cycle kinetics were analyzed by
cytoﬂuorimetric methods [72]. In Ayurvedic polyherbal
formulations, Emblica oﬃcinalis is a common constituent,
and most notably is the primary ingredient in an ancient
herbal preparation called Chyawanprash [73], which is itself
aneﬀectiveadaptogen and immunity booster that couldhelp
control swine ﬂu infection.
5.1.7. Tinospora cordifolia. Tinospora cordifolia, also called
Guduchi, is a herbaceous vine of the family Menispermaceae
indigenous to the tropical areas of India, Myanmar, and Sri
Lanka. The active constituents are diterpene compounds,
including tinosporone, tinosporic acid, cordifolisides A to
E, syringen, the yellow alkaloid, berberine, Giloin, crude
Giloininand, and a glucosidal bitter principle, as well as
polysaccharides, including arabinogalactan polysaccharide
(TSP) [74, 75]. These compounds possess adaptogenic
and immunomodulating properties. Picrotene and bergenin,
possessing antioxidant properties have been reported from
Tinospora. Tinospora cordifolia has been studied extensively
for its immunomodulating activities. The active principles
of Tinospora cordifolia were found to possess immunomod-
ulatory activities and caused signiﬁcant increases in IgG
antibodies in serum, along with macrophage activation
[76]. Enhancement in humoral immunity, evidenced by
the hemagglutination titre, along with stimulation of cell-
mediated immunity were observed in the leukocyte migra-
tion inhibition tests [77]. The plant has immense potential
for use against novel H1N1 ﬂu since it is a potent immunos-
timulant.
5.1.8. Mentha piperita. Mentha piperita, family Labiatae,
is a herbaceous rhizomatous perennial plant widely used
in Ayurveda [78]. It contains about 1.2%–1.5% essential
oil. The volatile oil, also known as menthae piperitae6 Evidence-Based Complementary and Alternative Medicine
aetheroleum, contains 30–70% free menthol, menthol esters
and more than 40 other compounds. The principal com-
ponents of the oil are menthol (29%), menthone (20%–
30%), and menthyl acetate (3%–10%). Pharmaceutical
grade oil, produced by distilling the fresh aerial parts
of the plant at the beginning of the ﬂowering cycle, is
standardized to contain no less than 44% menthol, 15%–
30% menthone, and 5% esters, in addition to various
terpenoids. Other compounds found in it are ﬂavonoids
(12%), polymerized polyphenols (19%), carotenes, toco-
pherols, betaine, and choline [79]. The antimicrobial and
a n t i v i r a la c t i v i t yo fm e n t h o lh a sb e e nr e p o r t e d .Mentha
piperita has signiﬁcant antiviral activity [80]. Menthol is
virucidal against inﬂuenza, herpes, and other viruses in vitro.
Aqueous extracts of peppermint leaves exhibited antiviral
activity against Inﬂuenza A, Newcastle disease virus, Herpes
simplex virus, and Vaccinia virus in egg and cell-culture
systems [81]. The oil contains terpenoids such as α-pinene
or β-pinene, α-phellandren, and also ester-connected with
menthol or free acetic acid and isovaleric acid, which are
mainly responsible for the antimicrobial activity of the herb
[82].
5.1.9. Azadirachta indica. Azadirachta indica (Neem in
Hindi) is a tree in the mahogany family Meliaceae. Three
bitter compounds that have been extracted from neem oil
are nimbin, nimbinin, and nimbidin, respectively [83]. The
seeds contain a complex secondary metabolite azadirachtin.
All parts of the plant yield β-sitosterol. The antiviral
activity of azadirachtin, nimbin, and nimbidin has been
reported. Azadirachta indica extracts possess antidiabetic,
antibacterial, and antiviral properties. The tree stem, root,
and bark possess astringent and tonic properties [84, 85].
In vitro antiviral activity of aqueous neem leaves extract,
assessed in cloned cells of larvae of Aedes albopictus cells
employing virus inhibition assay, showed inhibition in a
dose-dependent manner [86].
Azadirachta indica has traditionally been used as an
antiviral, and animal and laboratory research has shown
promising results. While researchers have still not pin-
pointed the exact mode of action of neem phytoconstituents,
there is some evidence to show that they interfere with
viral reproduction, thus minimizing the impact of viral
infections. The eﬀect of A. indica leaf extract and pure
compound (Azadirachtin) on the replication of Dengue
virus type-2 has also been reported. Thus, neem can
serve as a source of promising future antiviral drugs
[85].
5.1.10. Aegle marmelos. Aegle marmelos also called Bael
(Hindi) belongs to family Rutaceae. It contains primar-
ily alkaloids, coumarins, and steroids. The leaves contain
skimianinc, sterol, and aegelin. The active constituent of
the fruit is marmorosin, which is identical to imperatorin.
Coumarins contained in the fruits are altoimperatorin
and β sitosterol. Roots of the tree have been found to
contain psoralin, xanthotoxin, scopoletin, and tebamide. A.
marmelos from India is reported to possess imperetorin
[87], which has certain interesting biological properties such
as analgesic, anti-inﬂammatory, antibacterial, and antiviral
properties.
All parts of this tree-stem, bark, root, leaves, and fruit
at all stages of maturity have been used in Ayurveda since
ages. Medicated oil prepared from bael leaves gives relief
from recurrent colds and respiratory infections. Its regular
usebuildsupresistancetocoldsandcoughs.Theunripefruit
possesses signiﬁcant antiviral activity.
5.1.11. Trachyspermum ammi. Trachyspermum ammi, called
as Ajwain in Hindi and Bishops weed in English, is a
member of the family Apiaceae. The principal constituents
of the essential oil from the fruit are the phenols, mainly
thymol and some carvacrol. The oil possesses p-cymene,
g-terpinene, α-a n dβ-pinenes, and dipentene, minute
amounts of camphene, myrcene, and carene [88]. The
essential oil is a strong antiseptic [89], antispasmodic,
aromatic, bitter, diaphoretic, digestive, diuretic, expectorant,
and tonic [90]. It is used internally in the treatment
of colds, coughs, inﬂuenza, and asthma. The essential
oil is also added to various cough medicines as well
[89].
5.1.12. Andrographis paniculata. Andrographis paniculata
(Kalmegha in Hindi) is a herbaceous plant in the family
Acanthaceae, native to India and Sri Lanka. It is some-
times called “Indian Echinacea” because it is believed to
provide much the same beneﬁts as Echinacea. Andro-
grapholide, the major constituent of the extract is impli-
cated towards its pharmacological activity. Studies have
been conducted on the cellular processes and targets
modulated by andrographolide treatment of immune cells.
Andrographis was found to both reduce the symptoms
and shorten the duration of colds in clinical trials [90].
Andrographis paniculata also reduced the cold symp-
toms such as fatigue, sore throat, sore muscles, runny
nose, headache, and lymph node swelling [91]. Unlike
the Echinacea, Andrographis does not have any side
eﬀects.
5.1.13. Terminalia chebula Retz. Terminalia chebula,i sa
deciduous tree of family Combretaceae native to Southern
Asia from India and Nepal east to Southwestern China
(Yunnan), and south to Sri Lanka, Malaysia, and Vietnam.
It is regarded as a universal panacea. The dry nut’s peel
from this plant is used to cure cold-related nagging coughs.
The bark/peel of the nut is placed in the cheek and this
generates a huge amount of saliva as the material does
not dissolve. The resulting saliva, bitter in taste, is believed
to have medicinal qualities to cure cold related coughs.
Its fruits possess digestive, anti-inﬂammatory, anthelmentic,
cardiotonic, aphrodisiac, and restorative properties and
are additionally beneﬁcial in cough and colds. Termina-
lia chebula is an important medicine, which often pro-
motes health through successive steps of puriﬁcation and
detoxiﬁcation. It is known to have strong antimutagenic
activity, because of its very rich content vitamin C [92].
Also it is an established potent free radical scavenger
[93].Evidence-Based Complementary and Alternative Medicine 7
6. TraditionalChineseMedicine
Some plants that are extensively used in Traditional Chinese
Medicine and could prove useful for the management of
swine ﬂu are as follows.
6.1.Sophoraﬂavescens. Sophoraﬂavescensisaspeciesofplant
in the genus Sophora. Its roots are regionally called ku shen
or kushenin [94] which is the source of ﬂavonoids and is
used as traditional Chinese medicine [95]. Its roots also
contain quinolizidine alkaloids, including matrine and its
oxide [96], that interfere TNF-alpha and IL-6, suggesting
that oxymatrine may inhibit the expression of the above
proinﬂammatory cytokines [97]. Recent studies have shown
that the plant also contains 8-Prenylkaempferol (8-PK), a
prenylﬂavonoid in its roots. The principle bioactive con-
stituents of S. ﬂavescens are the major quinolizidine alkaloids
matrine (MT) and oxymatrine (OMT), which were reported
to exhibit sedative, depressant, antitumor, antipyretic, and
cardiotonic activities.
Due to its antiviral action, the plant has been the focus
of attention for innovative studies. The recent studies to
appraise its eﬃcacy against H1N1 infection have yielded
positive outcomes. Cell inoculation with H1N1 evoked a sig-
niﬁcant induction in RANTES accumulation accompanied
withtime-relatedincreaseinnucleartranslocationofnuclear
factor-κB( N F - κB) and interferon regulatory factor 3 (IRF-
3), but showed no eﬀect on c-Jun phosphorylation. 8-Pκ
could signiﬁcantly inhibit not only RANTES production, but
also NF-kappaB and IRF-3 nuclear translocation [98].
6.2. Toddalia asiatica. Toddalia asiatica (Lopez root) belongs
to family Rutaceae, a woody liana, found in mainly Philip-
pines and southern China. It is a large, spiny, woody vine,
which is pungent in all its parts and possesses sharp recurved
prickles. The leaves are trifoliolate. The leaﬂets are stalkless,
ovate-elliptic, 3 to 8 centimeters long, 5 to 15 millimeters
wide, rounded at the base, and pointed at the apex. The
ﬂowers are small, greenish-white, 5 millimeters across, and
borne on terminal cymes or from the upper leaf axils. The
fruit is small, nearly spherical, less than 1 centimeter in
diameter, borne in fairly large clusters, 3 to 5 grooved, and
with as many cells, and orange red when ripe. The seed
is solitary in each cell. T. asiatica is used traditionally in
the treatment of malaria, sprains, cough, fever, neuralgia,
epilepsy, dyspepsia, and other disease conditions. Extracts of
the plant have been reported to have anticancer, antimicro-
bial, antiviral (anti-HIV), and antifeedant activities. A wide
range of chemical constituents such as benzophenanthridine
alkaloids, coumarins, cyclohexylamides, and terpenoids have
been isolated especially from the root bark of the plant
[99]. The essential oil from the plant is a highly potent
antimicrobial agent [100, 101].
6.3. Scheﬄera heptaphylla, Chinese Herbal Tea. Scheﬄera
heptaphylla belongs to the family Scarabaeoidea. Leaves are
palmately compound, rarely unifoliolate (not in China);
margins entire to serrate; stipules united within petiole.
Inﬂorescence is a terminal or pseudolateral panicle or
compound raceme; ﬂowers arranged in umbels, heads, or
racemes; bracts pubescent, deciduous, or persistent. Pedicels
are not articulate below ovary. Calyx rim is entire or 5-
toothed. Petals are arranged 5-1, d are valvate. It is a critically
endangered species. It is polyphyletic [102–104].
∗Frodin is the principal ingredient of a herbal tea
formulation that is widely used for the treatment of
common cold in Southern China. An extract of the long
leafstalk of the compound leaf of S. heptaphylla exhibited
the most potent antiviral activity against respiratory
syncytial virus. Triterpenoids, namely, 3alpha-hydroxylup-
20[29]-ene-23,28-dioic acid and 3-epi-betulinic acid
3-O-sulfate, together with an inactive saponin, 3alpha-
hydroxylup-20(29)-ene-23,28-dioic acid 28-O-alpha-l-
rhamnopyranosyl-(1-->4)-O-beta-d-glucopyranosyl-(1-->6)-
beta-d-glucopyranoside are present in the plant [105].
Three caﬀeoylquinic acid derivatives, namely 3,4-di-O-
caﬀeoylquinic acid, 3,5-di-O-caﬀeoylquinic acid, and
3-O-caﬀeoylquinic acid, were also isolated from this plant.
These compounds were tested for their activity against
Respiratory Syncytial virus. Studies revealed that they
exerted their anti-RSV eﬀects via the inhibition of virus-cell
fusion in the early stage, and the inhibition of cell-cell fusion
at the end of the RSV replication cycle [106].
6.4. Camellia sinensis or Green Tea. Green tea is a type of
tea made solely from the leaves of Camellia sinensis that
has undergone minimal oxidation during processing. Green
tea originated in China and has now become associated
with many cultures in Asia from Japan to the Middle East.
Recently, it has become more widespread in the West, where
black tea is traditionally consumed.
Green tea is particularly rich in polyphenolic com-
pounds and catechins. Catechin derivatives have shown
pronounced antiviral activity, observed for derivatives car-
rying moderate chain length (7–9 carbons). The derivatives
exerted inhibitory eﬀects for all six inﬂuenza subtypes tested
including three major types of currently circulating human
inﬂuenza viruses (A/H1N1, A/H3N2, and B type), H2N2
and H9N2 avian inﬂuenza virus. The compounds strongly
inhibited adsorption of the viruses on red blood cell (RBC)
[107].
The disease preventive properties of green tea are mainly
due to the presence of polyphenols like epigallocatechin-
3-gallate (EGCG), epicatechin, epicatechin-3-gallate, and
epigallocatechin (EGC). These polyphenols comprise about
one-third of the weight of the dried leaf of the plant.
These catechins have been reported to possess diverse
pharmacological properties, including antioxidative, anti-
inﬂammatory, anticarcinogenic, antimutagenic and antimi-
crobial eﬀects. Green tea has the ability to enhance humoral
and cell-mediated immunity and is, therefore, useful for
preventing inﬂuenza by inhibiting ﬂu replication, using
potentially direct virucidal eﬀect [108].
6.5. Panax quinquefolius. Panax quinquefolius, commonly
known as American Ginseng, is an herbaceous perennial in
the ivy family that is commonly used in medicine. It is native
to Eastern North America, though it also cultivated beyond8 Evidence-Based Complementary and Alternative Medicine
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Figure 6: The mechanism of action of some isolated compounds from herbs and their role in prevention and treatment of novel H1N1 ﬂu.
its range in places such as China [109]. American ginseng
contains dammarane-type ginsenosides as the major bio-
logically active constituents. Dammarane type ginsenosides
include two classiﬁcations: the 20(S)-protopanaxadiol (ppd)
and 20(S)-protopanaxatriol (ppt) classiﬁcations. American
ginseng contains high levels of Rb1, Rd (ppd classiﬁcation),
and Re (ppt classiﬁcation) ginsenosides that are helpful
in prevention of common cold [110]. In Eastern Europe,
ginseng is widely used to improve overall immunity to
illness. It appears that regular use of ginseng may prevent
colds. Studies have been done on Panax to reveal that they
eﬀectively provide immunity to individuals against inﬂuenza
[111].
6.6. Echinacea. Echinacea is a genus of nine species of
herbaceous plants in the family Asteraceae. It is purely native
to North America. The principal eﬀect of these species is to
stimulate the body immune system. It appears to activate
the body’s infection-ﬁghting capacity, which is primarily
due to the presence of various chemical compounds such
as polysaccharides, phenols, alkylamides, and Cichoric acid.
Studies in Europe have concluded that Echinacea, when
t a k e na tﬁ r s ts i g no fc o l d ,r e d u c e dc o l ds y m p t o m so r
shortened their duration [112]. There is some evidence that,
when taken at the onset of a cold or ﬂu, Echinacea can
help patients recover faster and reduce their symptoms while
they are sick. For example, Echinacea signiﬁcantly reduced
symptoms such as headache, lethargy, cough, and aching
limbs [113, 114] when administered to people with ﬂu-like
illnesses. The constituents found in Echinacea were found to
increase antibody production, raise white blood cell counts,
and stimulate the activity of key white blood cells [115–118].
Some of the studies have also reported about the allergic
eﬀects of Echinacea. Echinacea should not be taken by per-
sons with progressive systemic and autoimmune disorders,
connective tissue disorders, or related diseases. It should
not be used with immunosuppressants or hepatotoxic drugs,
[119] and has the potential to interfere with anesthesia.
7. CAM for the Management of H1N1:
The WayAhead
From the foregoing account it is apparent that several
medicinal plants have the potential to be used eﬀectively for
the management of H1N1. These medicinal herbs mainly act
via two basic approaches against H1N1 infection, namely,Evidence-Based Complementary and Alternative Medicine 9
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enhancement of overall immunity of the individual or by
acting against the virus by preventing viral replication or
by inhibiting viral signal transduction. Table 1 enumerates
the various medicinal herbs from all over the globe that
have been found to be potent against the virus, while
Figure 6 aptly depicts that genetic modiﬁcations have led
to the evolution of the deadly H1N1 virus and discusses
the mechanistic aspects vis-a-vis isolated phytomolecules.
The herbs that boost the overall immunity of the body by
stimulating speciﬁc or nonspeciﬁc entities of the immune
system, thereby improving the individual’s ability to tackle
infections, have been listed in Table 2.
Antiviral agents have been isolated from plants as a result
of a recent resurgence of chemical and pharmacological
studies. These agents include a variety of polyphenols,
ﬂavonoids, saponins, glucosides, and alkaloids [15]. Such
isolated compounds may prove to be highly beneﬁcial in
controlling the mortality/morbidity rate resulting due to
H1N1 swine ﬂu since they target various pathways and act
at multifarious levels. The mechanisms by which some of
the potent bioactive compounds act have been elucidated to
some extent. For example kaempferol, isolated from Emblica
oﬃcinalis,a c t svia solubilisation of viral outer lipoprotein
[72]; azadirachtin, isolated from Azadirachta indica, hin-
ders the viral transduction [86]; glycyrrhizic acid from
Glycyrrhiza glabra [17] and ginkgolides from Ginkgo biloba
increase virus-speciﬁc antibodies in the infected individual.
Zingerone and gingerols from Zingiber oﬃcinalis prevent
viral replication and also intervene in the process of virus-
host fusion [63].
The need of the hour is not only to isolate and
characterize compounds from the various medicinal plants
but to utilize medium, high and ultrahigh-throughput
methodsofscreening,molecularproﬁling,whichwillinvolve10 Evidence-Based Complementary and Alternative Medicine
Table 1: List of medicinal plants from all over the world, which may prove useful to combat Swine ﬂu.
S. no. Plant and its
origin Native Family Principal chemical
compounds Anti-inﬂuenza action Reference
1 Clinacanthus
siamensis Thailand Acanthaceae
Trans-3-methylsulfonyl-
2-propenol,
trans-3-methylsulﬁnyl-
2-propenol
Signiﬁcant production of anti-inﬂuenza
virus IgG(1) antibody produced a higher
anti-inﬂuenza virus IgA antibody level.
[38]
2 Myrica rubra Japan Myricaceae
Phenolic compounds,
chlorogenic acid,
Catechol, Gallic acid
Anti-inﬂuenza virus activity irrespective
of the hemagglutinin antigen type in the
inﬂuenza virus type A (H1N1), its
subtype (H3N2), and type B.
[39]
3 Narcissus tazetta China Amaryllidaceae A fetuin-binding peptide
Signiﬁcantly inhibit the plaque formation
by respiratory syncytial virus (RSV) and
the cytopathic eﬀect induced by inﬂuenza
A (H1N1) virus.
[40]
4 Prunus mume Japan Rosaceae Presence of a lectin-like
molecule
Strong in vitro anti-inﬂuenza activity
against human inﬂuenza A viruses before
viral adsorption.
[41]
5 Cistus incanus Mediterranean Cistaceae Polymeric polyphenol
components
Inhibit binding of the hemagglutinin to
cellular receptors thereby, a local
application of the extract at the viral
entry routes may be a promising
approach and thus help to provide
protection from inﬂuenza virus
infections.
[42]
6 Pandanus
amaryllifolius
Malaysia,
Indonesia Pandanaceae A Lectin called Pandanin Possesses antiviral activities against
inﬂuenza virus (H1N1). [43]
8 Sophora
ﬂavescens Korea Leguminosae Pterocarpans and
ﬂavanones
Ability to inhibit neuraminidase an
enzyme identiﬁed as crucial for the
proliferation of the inﬂuenza virus.
[44]
9 Aronia
melanocarpa North America Rosaceae Phenolic substances
anthocyanins, glycosides
Antiviral activity against type A inﬂuenza
virus. [45]
10 Scheﬄera
heptaphylla China Araliaceae Frodin and Saponin Potent antiviral activity against
respiratory syncytial virus. [46]
11 Bergenia ligulata Nepal Saxifragaceae Condensed Tannins Inhibits viral RNA synthesis and reduces
viral peptide synthesis. [47]
12 Geranium
sanguineum Bulgaria Geraniaceae Polyphenols Inhibition of inﬂuenza virus protein
synthesis. [48]
13 Sambucus nigra Japan Caprifoliaceae
Kaempferol, astragalin,
quercetin, rutin,
isoquercitrin, hyperoside
Neutralize and reduce the infectivity of
inﬂuenza viruses A and B. [49]
14 Justicia
pectoralis Latin America Acanthaceae Coumarin and
umbelliferone
Possess anti-inﬂammatory and relaxant
eﬀects, and it supports recovery from
inﬂuenza.
[50]
15 Achillea
millefolium N. hemisphere Asteraceae
Isovaleric acid, salicylic
acid, asparagin, sterols,
ﬂavonoids, bitters,
tannins, and coumarins
A chest rub from this extract can be
eﬀective against inﬂuenza. [51]
16 Astragalus
Temperate
region of N.
hemisphere.
Fabaceae Cycloastregenol
Boosts the immune system thereby
provides shield against the Viral
infection.
[52]
17 Agathosma
betulina
Western-South
Africa. Rutaceae Isomenthone and
diosphenol
Natural antiviral that has antioxidant &
antiseptic activity & helps the body get
rid itself of toxins.
[53]
19 Olea europaea Mediterranean
Basin Oleaceae Phenolic compounds
and oleuropein
Natural antiviral; stimulates the immune
system. [54]Evidence-Based Complementary and Alternative Medicine 11
Table 1: Continued.
S. no. Plant and its
origin Native Family Principal chemical
compounds Anti-inﬂuenza action Reference
20 Junipers
Arctic region,
tropical Africa,
central America
Cupressaceae
α-pinene, camphene,
β-pinene, sabinene,
myrcene,
α-phellandrene,
α-terpinene
It has high Macrophage
immunomodulatory eﬃcacies. [55]
21 Cinnamomum
verum Sri Lanka Lauraceae Cinnamaldehyde, gum,
tannin, mannitol
Antioxidants and radical scavenger.
Prevents the entry of Virus. [56]
22 Scutellaria
baicalensis Japan Lamiaceae
5,7,4 -trihydroxy-8-
methoxyﬂavone (F36)
from the roots
Reduces the replication of inﬂuenza virus
A/PR/8/34 (A/PR8) by inhibiting the
fusion of the virus with
endosome/lysosome membrane which
occurs at early stage of viral infection
cycle.
[57]
23 Chrysanthemum
indicum India, China Asteraceae α-terpineol, cis-sabinol,
thujone, camphor
Chrysanthemum tea has many purported
medicinal uses, including an aid in
recovery from inﬂuenza.
[58]
Table 2: List of medicinal plants, from all over the world, which may prove useful in combating novel H1N1 ﬂu by stimulating immune
system.
Plant and its
origin Native Family Principal chemical compounds Anti-inﬂuenza action Reference
Quillaja
saponaria
Central
Chile Quillajaceae Glucoside saponin, tannins,
polyphenols, calcium oxalate
Facilitate the removal of phlegm
through coughing, hence aids in passive
immunity.
[65]
Echinacea
purpurea
North
America Compositae Cichoric acid, ethanol- and ethyl acetate
Echinacea increases the levels of a
chemical called properdin in the body
which activates part of the immune
system responsible for increasing the
defence mechanisms against bacteria
and viruses. It is also a potent anti-viral
photosensitizer.
[66]
Salvia
oﬃcinalis
Central and
Southwest-
ern Asia,
Mexico
Lamiaceae
4-hydroxy-acetophenone-4-O-β-D-
apiofuranosyl-(1→6)-O-β-D-
glucopyranoside
Salviae extract increased the levels of
inﬂuenza virus speciﬁc antibodies and
neutralizing activities also acts as
mucosal adjuvant and immune
modulator during inﬂuenza virus
infection.
[67]
Nicotiana
benthamiana Australia Solanaceae Capsanthin, Carotenoids, glycolipids.
Induce a protective immune response
against a lethal inﬂuenza viral challenge
in mice against the inﬂuenza.
[68]
Ginkgo biloba China and
Japan Ginkgoaceae Flavonoid glycosides and terpenoids
(ginkgolides, bilobalides)
Ginkgo, improves blood ﬂow and
improves immunity. [69]
Thuja
occidentalis
North
America,
Europe
Cupressaceae Thujone, Vitamin C Leukocyte and cytokine induction,
increases antibody response. [70]
Withania
somnifera India Solanaceae
Anaferine, anahygrine, beta-sisterol,
chlorogenic acid, cysteine,
cuscohygrine, pseudotropine,
scopoletin, somniferinine, withaferin α,
withanine, withananine, and
withanolides
Stimulant for the immune system, also a
very potent adaptogen. [71]12 Evidence-Based Complementary and Alternative Medicine
genomic and proteomic approaches and nanotechnology-
based antiviral drug development. It is anticipated that
rapid advances in the ﬁeld of bioinformatics would
lead in the future to improvisation of antiviral eﬀec-
tiveness of phytocompounds, via virtual antiviral screen-
ing of phytocompounds, for eﬀective management of
H1N1 ﬂu.
Figure 7 summarizes some of the medicinal plants.
8. Conclusion
Pandemic inﬂuenza has posed a global threat, though
currently the situation is fairly under control. However,
the society remains insuﬃciently equipped to handle the
outbreak from resistant strains if they were to occur
despite many years of advance warning and preparation
to handle such casualties. Mainstream medicine currently
does not have a vaccine. The vaccine when available
would be stockpiled along with antiviral drugs for use
to handle crisis emerging. However, immediately after the
launch it would be in short supply and ineﬀective, in a
pandemic situation, for treating the masses in developing
and underdeveloped nations. Besides the development of
drug resistance, emergence of mutant strains of the virus,
emergence of a more virulent strain, prohibitive costs of
available drugs, time lag between vaccine development, and
mass casualties would pose really diﬃcult problems. In view
of this, complementary and alternative medicine oﬀers a
plethora of interesting possibilities to help patients. Herbs
exhibit a diverse array of biological activities and can be
eﬀectivelyharnessedformanagingpandemicﬂu.Itisevident
that nutritional and botanical approaches, taken together,
provide very potent tools for controlling an array of viral
infections. It is unfortunate that many of these herbs have
been overlooked, and the initial exciting research ﬁndings
have not been followed up with larger, more rigorous clinical
trials. The availability of a wide range of potentially active
herbsandconstituents,topotentiateasanti-inﬂuenzaagents,
may have a leading role in the ongoing struggle against
the novel H1N1 infection. Herbal drugs would be useful,
but it should not be expected as a panacea for oﬀering
perfect protection or absolute cessation of symptoms, but
could be instead helpful in achieving reduced risk, symptom
reduction, and quicker recovery. This paper portrays an
eclectic overview for the treatment of pandemic inﬂuenza
and covers some of the herbs that are most likely to be of
deal help in managing the current pandemic scenario and
also to cope with the next pandemic that might appear in
the not-too-distant future. It is our ﬁrm belief that the plants
discussed in the paper would also be useful in treating the
patients with serious inﬂuenza in nonpandemic situations
too.
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